Inflamase mild side effects by duration, gender and age - a phase IV clinical study of FDA data
Summary:
Side effects are reported by people who take Inflamase mild. Common side effects include drug ineffective among males.
The phase IV clinical study is created by eHealthMe based on 2 reports from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
2 people who take Inflamase Mild and have side effects are studied.
What is Inflamase Mild?
Inflamase mild has active ingredients of prednisolone sodium phosphate. eHealthMe is studying from 2 Inflamase mild users for its effectiveness, alternative drugs and more.
Number of Inflamase mild reports submitted per year:
Inflamase Mild side effects by gender *:
female:
n/a
male:
- Drug ineffective
* Approximation only. Some reports may have incomplete information.
Do you take Inflamase mild?
Personalize this study to your gender and ageHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How the study uses the data?
The study is based on prednisolone sodium phosphate (the active ingredients of Inflamase mild) and Inflamase mild (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.
Related studies
Alternative drugs to, pros and cons of Inflamase mild:
- Inflamase mild (2 reports)
All Inflamase mild side effects from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zWho is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Allegra-D 12 Hour and Accolate drug interaction - now
- Zovirax and Combigan drug interaction - 3 seconds ago
- Ambisome and Olmesartan Medoxomil drug interaction - 5 seconds ago
- Aimovig and Clobazam drug interaction - 6 seconds ago
- Minivelle and Tachycardia Aggravated - 13 seconds ago
- Allegra D 24 Hour and Coq10 drug interaction - 18 seconds ago
- Glimepiride and Suicide Attempt - 20 seconds ago
- Minivelle and Arrhythmias - 21 seconds ago
- Omnicef and Gastroesophageal Reflux Disease - 29 seconds ago
- Linezolid and Proventil drug interaction - 32 seconds ago